Skip to main content

AbilityPharma: Accelerating Solutions for Pancreatic Cancer

Project description

New drug for the treatment of pancreatic cancer

Call for proposal

H2020-EIC-SMEInst-2018-2020

See other projects for this call

Sub call

H2020-EIC-SMEInst-2018-2020-3

Coordinator

ABILITY PHARMACEUTICALS SL
Net EU contribution
€ 2 325 865,38
Address
Edifici Eureka - Campus De La Uab
08193 Barcelona
Spain

See on map

Region
Este Cataluña Barcelona
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Other funding
€ 996 800,87